Insight of pancreatic cancer: recommendations for improving its therapeutic efficacy in the next decade

被引:9
|
作者
Xu, Zhi-Hang [1 ,2 ]
Wang, Wen-Quan [1 ,2 ]
Lou, Wen-Hui [1 ,2 ,3 ]
Liu, Liang [1 ,2 ,3 ]
机构
[1] Fudan Univ, Zhongshan Hosp, Dept Pancreat Surg, Shanghai, Peoples R China
[2] Fudan Univ, Shanghai Med Coll, Dept Oncol, Shanghai, Peoples R China
[3] Fudan Univ, Zhongshan Hosp, Dept Pancreat Surg, 180 Feng Lin Rd, Shanghai 200032, Peoples R China
基金
中国国家自然科学基金;
关键词
Chinese medicine; Diagnosis; Model; Pancreatic cancer; Prevention; Review; Therapy; ANTIBODY-DRUG CONJUGATE; DUCTAL ADENOCARCINOMA; ENHANCED RECOVERY; DISTINCT TUMOR; HIGH-RISK; SURGERY; PANCREATICODUODENECTOMY; DIAGNOSIS; SUBTYPES; SURVIVAL;
D O I
10.1097/JP9.0000000000000093
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Pancreatic cancer is one of the most malignant digestive system tumors. The effectiveness of pancreatic cancer treatment is still dismal, and the 5-year survival rate is only about 10%. Further improving the diagnosis and treatment of pancreatic cancer is the top priority of oncology research and clinical practice. Based on the existing clinical and scientific research experience, the review provides insight into the hotspots and future directions for pancreatic cancer, which focuses on early detection, early diagnosis, molecular typing and precise treatment, new drug development and regimen combination, immunotherapy, database development, model establishment, surgical technology and strategy change, as well as innovation of traditional Chinese medicine and breakthrough of treatment concept.
引用
收藏
页码:58 / 68
页数:11
相关论文
共 50 条
  • [1] Insight of pancreatic cancer: recommendations for improving its therapeutic efficacy in the next decade
    Xu Zhi-Hang
    Wang Wen-Quan
    Lou Wen-Hui
    Liu Liang
    胰腺病学杂志(英文), 2022, 05 (02)
  • [2] Current Insight into Novel Delivery Approaches of Resveratrol for Improving Therapeutic Efficacy and Bioavailability with its Clinical Updates
    Harwansh, Ranjit K.
    Yadav, Paras
    Deshmukh, Rohitas
    CURRENT PHARMACEUTICAL DESIGN, 2023, 29 (37) : 2921 - 2939
  • [3] Pancreatic Cancer, Gut Microbiota, and Therapeutic Efficacy
    Zhang, Xiang
    Liu, Qiaofei
    Liao, Quan
    Zhao, Yupei
    JOURNAL OF CANCER, 2020, 11 (10): : 2749 - 2758
  • [4] Improving therapeutic efficacy of Docetaxel in breast cancer
    King, Jeronay
    Mir, Nina
    Kapur, Neeraj
    Singh, Shailesh
    CANCER RESEARCH, 2015, 75
  • [5] Bratislava Statement: consensus recommendations for improving pancreatic cancer care
    Prades, Joan
    Arnold, Dirk
    Brunner, Thomas
    Cardone, Antonella
    Carrato, Alfredo
    Coll-Ortega, Cristina
    De Luze, Samuel
    Garel, Pascal
    Goossens, Maria E.
    Grilli, Roberto
    Harris, Meggan
    Louagie, Marleen
    Malats, Nuria
    Minicozzi, Pamela
    Partelli, Stefano
    Pastorekova, Silvia
    Petrulionis, Marius
    Price, Richard
    Sclafani, Francesco
    Smolkova, Bozena
    Borras, Josep M.
    ESMO OPEN, 2020, 5 (06)
  • [7] Therapeutic efficacy of CA102N in pancreatic cancer
    Lin, Louis
    Tu, Shuling
    Tchaparian, Eskouhie
    CANCER RESEARCH, 2024, 84 (06)
  • [8] Therapeutic resistance of pancreatic cancer: Roadmap to its reversal
    Yu, Sen
    Zhang, Chunyu
    Xie, Ke-Ping
    BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER, 2021, 1875 (01):
  • [9] A comprehensive review of pancreatic cancer and its therapeutic challenges
    Jiang, Shan
    Fagman, Johan Bourghardt
    Ma, Yunyun
    Liu, Jian
    Vihav, Caroline
    Engstrom, Cecilia
    Liu, Beidong
    Chen, Changyan
    AGING-US, 2022, 14 (18): : 7635 - 7649
  • [10] Improving the therapeutic efficacy of oncolytic viruses for cancer: targeting macrophages
    Zhen Shen
    Xiyu Liu
    Guixiang Fan
    Jintong Na
    Qiaoqiao Liu
    Faquan Lin
    Zhikun Zhang
    Liping Zhong
    Journal of Translational Medicine, 21